Publication Name	World Journal of Gastroenterology
Manuscript ID	3937
Country	Portugal

Received	2013-06-03 08:55
Peer-Review Started	2013-06-03 19:30
To Make the First Decision	2013-06-24 10:32
Return for Revision	2013-07-17 12:10
Revised	2013-07-25 07:11
Second Decision	2013-08-13 11:52
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2013-08-13 13:52
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2013-09-15 14:10
Publish the Manuscript Online	2013-10-18 17:02

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	HER2 therapies and gastric cancer: A step forward
Manuscript Source	Invited Manuscript
All Author List	Ramon Andrade de Mello, Andrea Marin Marques and António Araújo
Funding Agency and Grant Number	Funding Agency Grant Number Grants from Janssen and Merck Serono to de Mello RA
Corresponding Author	Ramon Andrade de Mello, MD, PhD, Department of Medical Oncology, Gastrointestinal Unit, Portuguese Oncology Institute, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal. ramondemello@gmail.com
Key Words	Gastric cancer; Trastuzumab; c-Met; Human epidermal growth factor receptor 2; Lapatinib; Pertuzumab
Core Tip	Approaches for treatment advanced gastric cancer are object of interesting debates toward scientific community worldwide over the last 20 years. Chemotherapy based on platinum and fluoropirimidine agents remained up to now the standard of care for those patients, otherwise triplet therapy either an anthracycline or taxane may be considered. Herein we provide an additional discussion regarding the role of biologic agents, such as trastuzumab and novel therapies for improve survival in this field.
Publish Date	2013-10-18 17:02
Citation	de Mello RA, Marques AM, Araújo A. HER2 therapies and gastric cancer: A step forward. World J Gastroenterol 2013; 19(37): 6165-6169
URL	http://www.wjgnet.com/1007-9327/full/v19/i37/6165.htm
DOI	http://dx.doi.org/10.3748/wjg.v19.i37.6165

Full Article (PDF)	WJG-19-6165.pdf
Manuscript File	3937-Review.doc
Answering Reviewers	3937-Answering reviewers.pdf
Copyright License Agreement	3937-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	3937-Language certificate.pdf
Peer-review Report	3937-Peer reviewer(s).pdf
Scientific Editor Work List	3937-Scientific editor work list.doc